ENTITY
SMARTSCORE: 2.4/5
Laurus Labs

Laurus Labs (LAURUS IN)

60
Analysis
Health CareIndia
Laurus Labs Limited researches, develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India and internationally. It offers APIs for anti-retroviral and hepatitis C; and APIs in oncology and other therapeutic areas. .
more
bullishLaurus Labs
02 May 2025 11:18

Laurus Labs Q4 FY25 Update: Diversification and Strategic R&D Drive Growth

​Laurus Labs sees 122% YoY increase in PAT for FY25, driven by CDMO success and margin growth, transforming into diversified CDMO/CMO business with...

Logo
331 Views
Share
bullishLaurus Labs
07 Mar 2025 03:30

The Beat Ideas: Laurus Labs

​Company faces short-term challenges with revenue and margins due to delays, but expects expansion and improved bottom line in FY26 and beyond with...

Logo
500 Views
Share
bullishLaurus Labs
29 Jan 2025 12:43Broker

Laurus Labs - Beat on Earnings; Green Shoots Visible

Laurus Lab (LAURUS) significantly beat our earnings estimates in 3QFY25, led by a scale-up in the CDMO segment.Commercial supplies (including...

Logo
179 Views
Share
bullishLaurus Labs
28 Oct 2024 16:42Broker

Laurus Labs - In-Line Quarter; CDMO Traction to Pick up in 2HFY25

Laurus Lab (LAURUS) delivered largely in-line operational performance for 2QFY25. It witnessed an improving traction in the CDMO business, with a...

Logo
237 Views
Share
12 Jun 2025 15:13

Divi's Laboratories (DIVI IN): Double-Digit Growth and Margin Improvement to Continue

​Divi's Laboratories finished FY25 strong. Moving ahead, the company is looking to maintain double-digit revenue growth. This compares favorably...

Logo
408 Views
Share
x